Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F
- PMID: 1555650
- DOI: 10.1016/0014-5793(92)80854-a
Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F
Abstract
The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, CTC----TTC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.
Similar articles
-
Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family.Blood. 1992 Mar 1;79(5):1206-12. Blood. 1992. PMID: 1536946
-
Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):323-30. doi: 10.1042/bj3100323. Biochem J. 1995. PMID: 7646463 Free PMC article.
-
Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.Biochemistry. 2002 Oct 15;41(41):12369-76. doi: 10.1021/bi020406j. Biochemistry. 2002. PMID: 12369826
-
Antithrombin 'DREUX' (Lys 114Glu): a variant with complete loss of heparin affinity.Thromb Haemost. 2002 Sep;88(3):436-43. Thromb Haemost. 2002. PMID: 12353073
-
Molecular genetics of antithrombin deficiency.Blood Rev. 1996 Jun;10(2):59-74. doi: 10.1016/s0268-960x(96)90034-x. Blood Rev. 1996. PMID: 8813337 Review.
Cited by
-
Glycosaminoglycans and the regulation of blood coagulation.Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):313-30. doi: 10.1042/bj2890313. Biochem J. 1993. PMID: 8380990 Free PMC article. Review. No abstract available.
-
Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics.Int J Mol Sci. 2021 Feb 20;22(4):2119. doi: 10.3390/ijms22042119. Int J Mol Sci. 2021. PMID: 33672736 Free PMC article.
-
Pleiotropic effects of antithrombin strand 1C substitution mutations.J Clin Invest. 1992 Dec;90(6):2422-33. doi: 10.1172/JCI116133. J Clin Invest. 1992. PMID: 1469094 Free PMC article.
-
Expression and functional characterization of two natural heparin-binding site variants of antithrombin.J Thromb Haemost. 2018 Feb;16(2):330-341. doi: 10.1111/jth.13920. Epub 2018 Jan 8. J Thromb Haemost. 2018. PMID: 29215785 Free PMC article.
-
Anticoagulant and signaling functions of antithrombin.J Thromb Haemost. 2020 Dec;18(12):3142-3153. doi: 10.1111/jth.15052. Epub 2020 Sep 9. J Thromb Haemost. 2020. PMID: 32780936 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases